I-H-Cys(Trt)-OH Cas: 2799-07-7
| Inombolo Yekhathalogi | XD91711 |
| Igama Lomkhiqizo | I-H-Cys(Trt)-OH |
| I-CAS | 2799-07-7 |
| Ifomu le-Molecularla | I-C22H21NO2S |
| Isisindo samangqamuzana | 363.47 |
| Imininingwane Yesitoreji | I-ambient |
| Ikhodi Yentela Evumelanisiwe | 29309090 |
Ukucaciswa Komkhiqizo
| Ukubukeka | Impushana emhlophe ukuya kokumhlophe |
| U-Asay | 99% iminithi |
| Iphoyinti lokuncibilika | 182-183 °C (dec.)(lit.) |
| Iphuzu elibilayo | 524.7±50.0 °C(Kubikezelwe) |
| ukuminyana | 1.1342 (isilinganiso esinzima) |
| inkomba ye-refractive | 111 ° (C=0.8, 0.04mol Ethanolic HCl) |
| pka | 2.22±0.10(Kubikezelwe) |
| umsebenzi optical | [α]25/D +115°, c = 0.8 ku-0.04 M ethanolic HCl |
I-cysteine evikelekile yokwenziwa kwe-peptide.I-S-Trityl-L-cysteine (STLC) iyi-tight-binding inhibitor ye-Eg5 evimbela ukuqhubeka kwe-mitotic.Ifakazelwe umsebenzi we-antitumor njengoba kukhonjisiwe ku-NCI 60 tumor cell line screen.
I-cysteine evikelekile yokwenziwa kwe-peptide.I-S-Trityl-L-cysteine (STLC) iyi-tight-binding inhibitor ye-Eg5 evimbela ukuqhubeka kwe-mitotic.Ifakazelwe umsebenzi we-antitumor njengoba kukhonjisiwe ku-NCI 60 tumor (+)-S-Trityl-L-cysteine, i-amino acid engeyona eyemvelo, enesulfure evame ukusetshenziswa njenge-reagent ku-solution phase peptide synthesis (SPPS).Iphinde isetshenziswe njenge-ejenti ebopha insimbi ukuze kuhlanganiswe ama-conjugates e-ferrocenoyl peptide esikhundleni kusetshenziswa i-HBTU peptide coupling reagent yesixazululo sezinhlelo zokusebenza ezinzwa i-cation ngesikrini somugqa we-peptide-metal interactions.cell.
